Zoroflox-OZ Tablet is a combination antibiotic formulation containing Ofloxacin 200 mg and Ornidazole 500 mg, designed for the treatment of mixed bacterial and protozoal infections. Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription. Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa, exerting its action by disrupting DNA synthesis and causing cell death. This synergistic combination is particularly useful in managing infections such as gastrointestinal infections, intra-abdominal infections, genitourinary tract infections, and certain sexually transmitted infections where mixed aerobic and anaerobic pathogens are implicated. Zoroflox-OZ is indicated for conditions including bacterial dysentery, amoebiasis, giardiasis, trichomoniasis, and complicated urinary tract infections. The tablet should be administered as prescribed by a healthcare professional, with dosage adjustments based on the severity of infection and patient response. Caution is advised in patients with hypersensitivity to fluoroquinolones or nitroimidazoles, and it is contraindicated during pregnancy and lactation. Adverse effects may include gastrointestinal disturbances, dizziness, and hypersensitivity reactions. Proper adherence to prescribed therapy is essential to prevent resistance development and ensure therapeutic efficacy.